Pharmaphorum Media Limited - Accounts to registrar (filleted) - small 18.2

Pharmaphorum Media Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v19.1.0.729 07254094 Board of Directors 1.1.18 31.12.18 31.12.18 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure072540942017-12-31072540942018-12-31072540942018-01-012018-12-31072540942016-12-31072540942017-01-012017-12-31072540942017-12-3107254094ns15:EnglandWales2018-01-012018-12-3107254094ns14:PoundSterling2018-01-012018-12-3107254094ns10:Director12018-01-012018-12-3107254094ns10:PrivateLimitedCompanyLtd2018-01-012018-12-3107254094ns10:SmallEntities2018-01-012018-12-3107254094ns10:AuditExemptWithAccountantsReport2018-01-012018-12-3107254094ns10:SmallCompaniesRegimeForDirectorsReport2018-01-012018-12-3107254094ns10:SmallCompaniesRegimeForAccounts2018-01-012018-12-3107254094ns10:FullAccounts2018-01-012018-12-310725409412018-01-012018-12-3107254094ns10:Director22018-01-012018-12-3107254094ns10:CompanySecretary12018-01-012018-12-3107254094ns10:RegisteredOffice2018-01-012018-12-3107254094ns5:CurrentFinancialInstruments2018-12-3107254094ns5:CurrentFinancialInstruments2017-12-3107254094ns5:ShareCapital2018-12-3107254094ns5:ShareCapital2017-12-3107254094ns5:RetainedEarningsAccumulatedLosses2018-12-3107254094ns5:RetainedEarningsAccumulatedLosses2017-12-3107254094ns5:IntangibleAssetsOtherThanGoodwill2018-01-012018-12-3107254094ns5:LeaseholdImprovements2018-01-012018-12-3107254094ns5:FurnitureFittings2018-01-012018-12-3107254094ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2017-12-3107254094ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2018-01-012018-12-3107254094ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2018-12-3107254094ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2017-12-3107254094ns5:LeaseholdImprovements2017-12-3107254094ns5:FurnitureFittings2017-12-3107254094ns5:LeaseholdImprovements2018-12-3107254094ns5:FurnitureFittings2018-12-3107254094ns5:LeaseholdImprovements2017-12-3107254094ns5:FurnitureFittings2017-12-3107254094ns5:CurrentFinancialInstrumentsns5:WithinOneYear2018-12-3107254094ns5:CurrentFinancialInstrumentsns5:WithinOneYear2017-12-3107254094ns5:CurrentFinancialInstruments2018-01-012018-12-3107254094ns5:WithinOneYear2018-12-3107254094ns5:WithinOneYear2017-12-3107254094ns5:BetweenOneFiveYears2018-12-3107254094ns5:BetweenOneFiveYears2017-12-3107254094ns5:AllPeriods2018-12-3107254094ns5:AllPeriods2017-12-31


REGISTERED NUMBER: 07254094 (England and Wales)















PHARMAPHORUM MEDIA LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2018






PHARMAPHORUM MEDIA LIMITED (REGISTERED NUMBER: 07254094)

CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 31 December 2018










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4

Chartered Accountants' Report 8

PHARMAPHORUM MEDIA LIMITED

COMPANY INFORMATION
for the year ended 31 December 2018







Directors: Dr M H A Sacoor
Dr P Tunnah





Secretary: Mr P Bannister





Registered office: Rosemount House
Rosemount Avenue
West Byfleet
KT14 6LB





Registered number: 07254094 (England and Wales)





Accountants: JPS Accountancy Limited
Chartered Accountants
Thorncroft Manor
Thorncroft Drive
Leatherhead
Surrey
KT22 8JB

PHARMAPHORUM MEDIA LIMITED (REGISTERED NUMBER: 07254094)

BALANCE SHEET
31 December 2018

2018 2017
Notes £    £   
FIXED ASSETS
Intangible assets 4 74,540 28,334
Tangible assets 5 2,823 14,015
77,363 42,349

CURRENT ASSETS
Debtors 6 378,421 435,389
Cash at bank 951 18,044
379,372 453,433
CREDITORS
Amounts falling due within one year 7 (1,161,073 ) (1,082,155 )
NET CURRENT LIABILITIES (781,701 ) (628,722 )
TOTAL ASSETS LESS CURRENT LIABILITIES (704,338 ) (586,373 )

CAPITAL AND RESERVES
Called up share capital 105 105
Retained earnings (704,443 ) (586,478 )
SHAREHOLDERS' FUNDS (704,338 ) (586,373 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2018.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2018 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the
end of each financial year and of its profit or loss for each financial year in accordance with the requirements of
Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to
financial statements, so far as applicable to the company.

PHARMAPHORUM MEDIA LIMITED (REGISTERED NUMBER: 07254094)

BALANCE SHEET - continued
31 December 2018


The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss account has not been delivered.

The financial statements were approved by the Board of Directors on 10 June 2019 and were signed on its behalf by:





Dr P Tunnah - Director


PHARMAPHORUM MEDIA LIMITED (REGISTERED NUMBER: 07254094)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 December 2018


1. STATUTORY INFORMATION

Pharmaphorum Media Limited is a private company, limited by shares , registered in England and Wales. The
company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities"
of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of
Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost
convention unless otherwise stated below.

The financial statements have been prepared on a going concern basis. This is considered appropriate by the
directors due to the anticipated future profitability of the company and on the basis that the shareholders and
an associated company will continue to support the company for the foreseeable future to enable liabilities to
be met as they fall due.

Turnover
Turnover represents the fair value of the consideration receivable for the sale of services in the ordinary course
of the business, excluding value added tax. In the case of long term contracts, credit is taken appropriate to the
stage of completion when the outcome of the contract can be assessed with reasonable certainty.

Intangible assets
Intangible fixed assets include website development costs where their future recoverability can reasonable be
regarded as assured. Amortisation is provided at an annual rate of 33% on cost.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Leasehold improvements - Over the period of the lease
Office equipment - straight line over 3 years

Financial instruments
Financial assets and liabilities are recognised when the company becomes party to the contractual provisions
of the instrument. All financial assets and liabilities are initially measured at transaction price. The company
has no financial assets or liabilities measured at fair value through profit or loss. All subsequent
remeasurement of financial assets and liabilities are recognised at amortised cost using the effective interest
rate method.

Taxation
Taxation for the year comprises current and deferred tax. Current tax is recognised at the amount of tax
payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet
date.


PHARMAPHORUM MEDIA LIMITED (REGISTERED NUMBER: 07254094)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2018


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the
balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different
from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and
laws that have been enacted or substantively enacted by the year end and that are expected to apply to the
reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that
they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the
balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange
ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating
result.

Operating leases
Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain
with the lessor are charged to the profit and loss account as incurred. The benefits of lease incentives are
recognised in the profit and loss account over the life of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's
pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 14 (2017 - 17 ) .

4. INTANGIBLE FIXED ASSETS
Website
development
costs
£   
Cost
At 1 January 2018 101,076
Additions 60,853
At 31 December 2018 161,929
Amortisation
At 1 January 2018 72,742
Amortisation for year 14,647
At 31 December 2018 87,389
Net book value
At 31 December 2018 74,540
At 31 December 2017 28,334

PHARMAPHORUM MEDIA LIMITED (REGISTERED NUMBER: 07254094)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2018


5. TANGIBLE FIXED ASSETS
Leasehold Office
improvements equipment Totals
£    £    £   
Cost
At 1 January 2018 33,344 20,955 54,299
Additions - 1,898 1,898
At 31 December 2018 33,344 22,853 56,197
Depreciation
At 1 January 2018 27,460 12,824 40,284
Charge for year 5,884 7,206 13,090
At 31 December 2018 33,344 20,030 53,374
Net book value
At 31 December 2018 - 2,823 2,823
At 31 December 2017 5,884 8,131 14,015

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2018 2017
£    £   
Trade debtors 134,708 223,788
Other debtors 243,713 211,601
378,421 435,389

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2018 2017
£    £   
Bank loans and overdrafts 215,341 218,328
Trade creditors 130,936 54,300
Taxation and social security 27,708 25,745
Other creditors 787,088 783,782
1,161,073 1,082,155

The amount included within bank loans and overdrafts is secured by way of fixed and floating charge over the
assets of the company in favour of Barclays Bank PLC.

PHARMAPHORUM MEDIA LIMITED (REGISTERED NUMBER: 07254094)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2018


8. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2018 2017
£    £   
Within one year 37,700 22,500
Between one and five years 65,975 -
103,675 22,500

CHARTERED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS
ON THE UNAUDITED FINANCIAL STATEMENTS OF
PHARMAPHORUM MEDIA LIMITED


The following reproduces the text of the report prepared for the directors in respect of the company's annual
unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a
Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the
Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the
financial statements of Pharmaphorum Media Limited for the year ended 31 December 2018 which comprise the
Profit and Loss account, Balance Sheet and the related notes from the company's accounting records and from
information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of Pharmaphorum Media Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Pharmaphorum Media Limited and state those matters that we have agreed to state to the Board of Directors of Pharmaphorum Media Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Pharmaphorum Media Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Pharmaphorum Media Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Pharmaphorum Media Limited. You consider that Pharmaphorum Media Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Pharmaphorum Media Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






JPS Accountancy Limited
Chartered Accountants
Thorncroft Manor
Thorncroft Drive
Leatherhead
Surrey
KT22 8JB


10 June 2019